Legal Opinion

Bristol-Myers Squibb Co. v. Novartis Pharma AG

District Court, S.D. New York

Decided June 14, 2022No. 1:22-cv-04162Unknown

1Opinion

~ || USDC SDNY UNITED STATES DISTRICT COURT DOCUMENT SOUTHERN DISTRICT OF NEW YORK x || ELECTRONICALLY FILED DOC #: BRISTOL-MYERS SQUIBB CO., | DATE FILED:__¢ > eee Petitioner, □ No. 22-cv-04162 (CM) v. NOVARTIS PHARMA AG, Respondent. MEMORANDUM DECISION AND ORDER DENYING RESPONDENT’S MOTION TO SEAL THE FINAL ARBITRATION AWARD McMahon, J.: On May 20, 2022, Petitioner Bristol-Myers Squibb Co. (“BMS”) filed a petition to confirm the final award that was entered in a binding arbitration between BMS and Novartis on June 16, 2021. (Dkt. No. 1). On May 23, 2020, Respondent Novartis Pharma AG’s…

2Cases cited8 opinions

  1. Lugosch v. Pyramid Co. of OnondagaCourt of Appeals for the Second Circuit · 2006
  2. United States v. AmodeoCourt of Appeals for the Second Circuit · 1995
  3. In Re New York Times CompanyCourt of Appeals for the Second Circuit · 1987
  4. Kimble v. Marvel Entertainment, LLCSupreme Court of the United States · 2015
  5. Brulotte v. Thys Co.Supreme Court of the United States · 1964

3 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API